The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on the level of DNA damage in heterozygous familial hypercholesterolaemia (HEFH)

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2023-08, Vol.379, p.S37-S38
Main Authors: Woźniak, E., Gorzelak-Pabiś, P., Woźniak, A., Pawlos, A., Bukowska, B., Broncel, M.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
DOI:10.1016/j.atherosclerosis.2023.06.172